Cerebral aneurysm rupture after r-TPA thrombolysis for acute myocardial infarction

被引:25
作者
Lagares, A
Gómez, PA
Lobato, RD
Alén, JF
Campollo, J
Benito-León, J
机构
[1] Hosp 12 Octubre, Neurosurg Serv, Madrid 28041, Spain
[2] Hosp 12 Octubre, Serv Neuroradiol, Madrid 28041, Spain
[3] Hosp Gen Mostoles, Neurol Serv, Madrid, Spain
来源
SURGICAL NEUROLOGY | 1999年 / 52卷 / 06期
关键词
thrombolysis; myocardial infarction; cerebral aneurysm; subarachnoid hemorrhage;
D O I
10.1016/S0090-3019(99)00147-0
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
BACKGROUND Intracranial hemorrhage is the most dreaded risk of thrombolytic therapy for acute myocardial infarction because of the high mortality and disability rates associated with this complication. Brain structural lesions may predispose a patient to bleeding. To date, aneurysm rupture has not been described as a complication of such therapy. CASE DESCRIPTION A 66-year-old hypertensive woman was admitted because of chest pain. Myocardial infarction was diagnosed and fibrinolytic therapy with recombinant tissue plasminogen activator (r-TPA) was initiated. Eight hours after admission she became unconscious. Brain computed tomography scan showed subarachnoid hemorrhage, and a cerebral arteriography showed an anterior communicating artery aneurysm. Because of her poor clinical Condition treatment was postponed. Death occurred 7 days later because of multiorgan failure. CONCLUSIONS Cerebral aneurysms should be considered as a possible contributing factor to intracranial bleeding after thrombolytic therapy. (C) 1999 by Elsevier Science Inc.
引用
收藏
页码:623 / 626
页数:4
相关论文
共 14 条
[2]  
Finney LA, 1967, JAMA-J AM MED ASSOC, V200, P203
[3]   Thrombolysis-related intracranial hemorrhage - A radiographic analysis of 244 cases from the GUSTO-1 trial with clinical correlation [J].
Gebel, JM ;
Sila, CA ;
Sloan, MA ;
Granger, CB ;
Mahaffey, KW ;
Weisenberger, J ;
Green, CL ;
White, HD ;
Gore, JM ;
Weaver, WD ;
Califf, RM ;
Topol, EJ .
STROKE, 1998, 29 (03) :563-569
[4]   STROKE AFTER THROMBOLYSIS - MORTALITY AND FUNCTIONAL OUTCOMES IN THE GUSTO-I TRIAL [J].
GORE, JM ;
GRANGER, CB ;
SIMOONS, ML ;
SLOAN, MA ;
WEAVER, D ;
WHITE, HD ;
BARBASH, GI ;
VANDEWERF, F ;
AYLWARD, PE ;
TOPOL, EJ ;
CALIFF, RM .
CIRCULATION, 1995, 92 (10) :2811-2818
[5]   Risk for intracranial hemorrhage after tissue plasminogen activator treatment for acute myocardial infarction [J].
Gurwitz, JH ;
Gore, JM ;
Goldberg, RJ ;
Barron, HV ;
Breen, T ;
Rundle, AC ;
Sloan, MA ;
French, W ;
Rogers, WJ .
ANNALS OF INTERNAL MEDICINE, 1998, 129 (08) :597-+
[6]   Preliminary results on the management of unruptured intracranial aneurysms with magnetic resonance angiography and computed tomographic angiography [J].
Harrison, MJ ;
Johnson, BA ;
Gardner, GM ;
Welling, BG .
NEUROSURGERY, 1997, 40 (05) :947-955
[7]   Asymptomatic familial cerebral aneurysms [J].
Kojima, M ;
Nagasawa, S ;
Lee, YE ;
Takeichi, Y ;
Tsuda, E ;
Mabuchi, N .
NEUROSURGERY, 1998, 43 (04) :776-781
[8]   HEMORRHAGIC COMPLICATIONS OF THROMBOLYTIC THERAPY [J].
LAUER, JE ;
HEGER, JJ ;
MIRRO, MJ .
CHEST, 1995, 108 (06) :1520-1523
[9]   RUPTURED ARTERIOVENOUS MALFORMATION COMPLICATING THROMBOLYTIC THERAPY WITH TISSUE PLASMINOGEN-ACTIVATOR [J].
PRONER, J ;
ROSENBLUM, BR ;
ROTHMAN, A .
ARCHIVES OF NEUROLOGY, 1990, 47 (01) :105-106
[10]   INDIVIDUAL RISK ASSESSMENT FOR INTRACRANIAL HEMORRHAGE DURING THROMBOLYTIC THERAPY [J].
SIMOONS, ML ;
MAGGIONI, AP ;
KNATTERUD, G ;
LEIMBERGER, JD ;
DEJAEGERE, P ;
VANDOMBURG, R ;
BOERSMA, E ;
FRANZOSI, MG ;
CALIFF, R ;
SCHRODER, R ;
BRAUNWALD, E .
LANCET, 1993, 342 (8886-7) :1523-1528